Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209777

Expand all

ROXYBOND (OXYCODONE HYDROCHLORIDE)
5MG
Marketing Status: Prescription

Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 001
Approval Date: Apr 20, 2017
Applicant Holder Full Name: PROTEGA PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ROXYBOND (OXYCODONE HYDROCHLORIDE)
15MG
Marketing Status: Prescription

Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 002
Approval Date: Apr 20, 2017
Applicant Holder Full Name: PROTEGA PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ROXYBOND (OXYCODONE HYDROCHLORIDE)
30MG
Marketing Status: Prescription

Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 003
Approval Date: Apr 20, 2017
Applicant Holder Full Name: PROTEGA PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information